Literature DB >> 31621101

Cell Fate Regulation upon DNA Damage: p53 Serine 46 Kinases Pave the Cell Death Road.

Magdalena C Liebl1, Thomas G Hofmann1.   

Abstract

Mild and massive DNA damage are differentially integrated into the cellular signaling networks and, in consequence, provoke different cell fate decisions. After mild damage, the tumor suppressor p53 directs the cellular response to cell cycle arrest, DNA repair, and cell survival, whereas upon severe damage, p53 drives the cell death response. One posttranslational modification of p53, phosphorylation at Serine 46, selectively occurs after severe DNA damage and is envisioned as a marker of the cell death response. However, the molecular mechanism of action of the p53 Ser46 phospho-isomer, the molecular timing of this phosphorylation event, and its activating effects on apoptosis and ferroptosis still await exploration. In this essay, the current body of evidence on the molecular function of this deadly p53 mark, its evolutionary conservation, and the regulation of the key players of this response, the p53 Serine 46 kinases, are reviewed and dissected.
© 2019 The Authors. BioEssays Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  DNA damage; HIPK2; apoptosis; cancer; ferroptosis; kinase; p53 Serine 46

Mesh:

Substances:

Year:  2019        PMID: 31621101     DOI: 10.1002/bies.201900127

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  12 in total

1.  Silence of MLK3 alleviates lipopolysaccharide-induced lung epithelial cell injury via inhibiting p53-mediated ferroptosis.

Authors:  Xiangjun Chen; Gangqiang Qi; Fang Fang; Yi Miao; Li Wang
Journal:  J Mol Histol       Date:  2022-03-05       Impact factor: 2.611

Review 2.  Post-Translational Modifications of p53 in Ferroptosis: Novel Pharmacological Targets for Cancer Therapy.

Authors:  Le Zhang; Ningning Hou; Bing Chen; Chengxia Kan; Fang Han; Jingwen Zhang; Xiaodong Sun
Journal:  Front Pharmacol       Date:  2022-05-24       Impact factor: 5.988

3.  Protective Role of Decorin in Primary Hepatocellular Carcinoma.

Authors:  Andrea Reszegi; Zsolt Horváth; Hajnalka Fehér; Barnabás Wichmann; Péter Tátrai; Ilona Kovalszky; Kornélia Baghy
Journal:  Front Oncol       Date:  2020-05-12       Impact factor: 6.244

4.  Biological Basis for Threshold Responses to Methylating Agents.

Authors:  Adam D Thomas
Journal:  Chem Res Toxicol       Date:  2020-05-27       Impact factor: 3.739

Review 5.  Emerging roles of DYRK2 in cancer.

Authors:  Vasudha Tandon; Laureano de la Vega; Sourav Banerjee
Journal:  J Biol Chem       Date:  2021-01-07       Impact factor: 5.157

6.  ZNF498 promotes hepatocellular carcinogenesis by suppressing p53-mediated apoptosis and ferroptosis via the attenuation of p53 Ser46 phosphorylation.

Authors:  Xiuyuan Zhang; Qijian Zheng; Xiuying Yue; Zhanna Yuan; Jiming Ling; Yanzhi Yuan; Yanying Liang; Aihua Sun; Yuchen Liu; Hui Li; Kaikun Xu; Fuchu He; Jian Wang; Jin Wu; Chunling Zhao; Chunyan Tian
Journal:  J Exp Clin Cancer Res       Date:  2022-02-28

7.  The small Cajal body-specific RNA 15 (SCARNA15) directs p53 and redox homeostasis via selective splicing in cancer cells.

Authors:  Giulia Beneventi; Roberto Munita; Phuong Cao Thi Ngoc; Magdalena Madej; Maciej Cieśla; Sowndarya Muthukumar; Nicolai Krogh; Henrik Nielsen; Vinay Swaminathan; Cristian Bellodi
Journal:  NAR Cancer       Date:  2021-07-09

Review 8.  Regulating tumor suppressor genes: post-translational modifications.

Authors:  Ling Chen; Shuang Liu; Yongguang Tao
Journal:  Signal Transduct Target Ther       Date:  2020-06-10

9.  GM-CSF and IL-33 Orchestrate Polynucleation and Polyploidy of Resident Murine Alveolar Macrophages in a Murine Model of Allergic Asthma.

Authors:  Katharina M Quell; Kuheli Dutta; Ülkü R Korkmaz; Larissa Nogueira de Almeida; Tillman Vollbrandt; Peter König; Ian Lewkowich; George S Deepe; Admar Verschoor; Jörg Köhl; Yves Laumonnier
Journal:  Int J Mol Sci       Date:  2020-10-11       Impact factor: 5.923

Review 10.  p53 signaling in cancer progression and therapy.

Authors:  Hany E Marei; Asmaa Althani; Nahla Afifi; Anwarul Hasan; Thomas Caceci; Giacomo Pozzoli; Andrea Morrione; Antonio Giordano; Carlo Cenciarelli
Journal:  Cancer Cell Int       Date:  2021-12-24       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.